Cargando…
Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy
BACKGROUND: Resistance to trastuzumab is a clinical problem, partly due to overriding activation of MAPK/PI3K signalling. Sprouty-family proteins are negative regulators of MAPK/PI3K signalling, but their role in HER2-therapy resistance is unknown. PATIENTS AND METHODS: Associations between Sprouty...
Autores principales: | Faratian, Dana, Sims, Andrew H., Mullen, Peter, Kay, Charlene, Um, InHwa, Langdon, Simon P., Harrison, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166119/ https://www.ncbi.nlm.nih.gov/pubmed/21909357 http://dx.doi.org/10.1371/journal.pone.0023772 |
Ejemplares similares
-
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in
ovarian cancer
por: Sims, A H, et al.
Publicado: (2012) -
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal
Cancer Cell Lines to Identify Novel Biomarkers
por: Briffa, Romina, et al.
Publicado: (2015) -
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer
por: Huang, Rui, et al.
Publicado: (2015) -
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
por: Faratian, Dana, et al.
Publicado: (2011) -
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
por: Koussounadis, Antonis, et al.
Publicado: (2016)